Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid

Metabolism: Clinical and Experimental

Volumn 46, Issue 10, 1997, Pages 1166-1170

  Arii, Kaoru ^a   Suehiro, Tadashi ^a   Yamamoto, Michiya ^a   Ito, Hiroyuki ^a   Hashimoto, Kozo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN INFUSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL;

EID: 0030876417     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90211-0     Document Type: Article

References (36)

1. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 34:1255-1274, 1993 (review)
2. Lagrost L: Regulation of cholesteryl ester transfer protein (CETP) activity: Review of in vitro and in vivo studies. Biochim Biophys Acta 1215:209-236, 1994
3. Sammett D, Tall AR: Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem 260:6687-6697, 1985
4. Morton RE: Binding of plasma-derived lipid transfer protein to lipoprotein substrates. The role of binding in the lipid transfer process. J Biol Chem 260:12593-12599, 1985
5. Milner TG, Ko KW, Ohnishi T, et al: Enhancement of the human plasma Iipid transfer protein reaction by apolipoproteins. Biochim Biophys Acta 1082:71-78, 1991
6. Guyard DV, Lagrost L, Gambert P: Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. J Lipid Res 35:982-992, 1994
7. Lagrost L, Persegol L, Lallemant C, et al: Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and All. J Biol Chem 269:3189-3197, 1994
8. Fielding CJ, Reaven GM, Liu G, et al: Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: Its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA 81:2512-2516, 1984
9. Bagdade JD, Lane JT, Subbaiah PV, et al: Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus. Atherosclerosis 104:69-77, 1993
10. Dullaart RP, Groener JE, Dikkeschei LD, et al: Increased cholesteryl ester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus - Its relationship with serum lipids. Diabetologia 32:14-19, 1989
11. Bagdade JD, Ritter MC, Subbaiah PV: Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 21:161-167, 1991
12. Bagdade JD, Dunn FL, Eckel RH, et al: Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. Arterioscler Thromb 14:1933-1939, 1994
13. Sutherland WH, Walker RJ, Lewis BN, et al: The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 43:1362-1366, 1994
14. World Health Organization: Diabetes mellitus: Report of a WHO Study Group. WHO Tech Rep Ser 727:9-17, 1985
15. Takahashi K, Jiang XC, Sakai N, et al: A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest 92:2060-2064, 1993
16. Brown ML, Inazu A, Hesler CB, et al: Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342:448-451, 1989
17. Inazu A, Jiang XC, Haraki T, et al: Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 94:1872-1882, 1994
18. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
19. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86, 1985
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
21. Albers JJ, Tollefson JH, Chen CH, et al: Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 4:49-58, 1984
22. Lewis GF, Uffelman KD, Szeto LW, et al: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42:833-842, 1993
23. Cummings MH, Watts GF, Umpleby AM, et al: Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 44:1059-1065, 1995
24. Sparks JD, Sparks CE: Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem 265:8854-8862, 1990
25. Farese RV Jr, Yost TJ, Robert HE, et al: Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 40:214-216, 1991
26. Yki JH, Taskinen MR, Koivisto VA, et al: Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetologia 27:364-369, 1984
27. Lagrost L, Florentin E, Guyard DV, et al: Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler, Thromb Vasc Biol 15:1388-1396, 1995
28. Faust RA, Albers JJ: Regulated vectorial secretion of cholesteryl ester transfer protein (LTP-I) by the CaCo-2 model of human enterocyte epithelium. J Biol Chem 263:8786-8789, 1988
29. Sperker B, Mark M, Budzinski RM: The expression of human plasma cholesteryl-ester-transfer protein in HepG2 cells is induced by sodium butyrate. Quantification of low mRNA levels by polymerase chain reaction. Eur J Biochem 218:945-950, 1993
30. Campbell PJ, Carlson MG, Hill JO, et al: Regulation of free fatty acid metabolism by insulin in humans: Role of lipolysis and reesterification. Am J Physiol 263:E1063-E1069, 1992
31. Groop LC, Bonadonna RC, DelPrato S, et al: Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus: Evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213, 1989
32. Zhong S, Goldberg IJ, Bruce C, et al: Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest 94:2457-2467, 1994
33. Tall A, Sammett D, Granot E: Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest 77:1163-1172, 1986
34. Quig DW, Zilversmit DB: Plasma lipid transfer activity in rabbits: Effects of dietary hyperlipidemias. Atherosclerosis 70:263-271, 1988
35. Abbey M, Clifton PM, McMurchie EJ, et al: Effect of a high fat/cholesterol diet with or without eicosapentaenoic acid on plasma lipids, lipoproteins and lipid transfer protein activity in the marmoset. Atherosclerosis 81:163-174, 1990
36. Quig DW, Arbeeny CM, Zilversmit DB: Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma. Biochim Biophys Acta 1083:257-264, 1991